Sarah Butler, Director at Australian Clinical Labs Ltd, holds 40.62K shares in Australian Clinical Labs Ltd (Ticker: AU:ACL), holds 33.50K shares in Nanosonics Limited (Ticker: NNCSF). Most recently, Sarah Butler Bought ― shares of Australian Clinical Labs Ltd on Sep 14, 2026 for an estimated value of AU$49.86K.
What is the percentage of profitable transactions made by Sarah Butler?
The percentage of profitable transactions made by Sarah Butler is 33%.
What is the average return per transaction made by Sarah Butler?
The average return per transaction made by Sarah Butler is 4.20%.
What stocks does Sarah Butler hold?
Sarah Butler holds: AU:ACL, NNCSF stocks.
What was Sarah Butler’s latest transaction?
Sarah Butler latest transaction was an Informative Buy of AU$49.86K.
What was Sarah Butler's most profitable transaction?
Sarah Butler’s most profitable transaction was an Informative Buy of AU:ACL stock on February 20, 2026. The return on the trade was 27.10%.
What is Sarah Butler's role in Australian Clinical Labs Ltd?
Sarah Butler's role in Australian Clinical Labs Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.